loadpatents
Patent applications and USPTO patent grants for Isis Pharmaceutical, Inc..The latest application filed is for "antidotes to antisense compounds".
Patent | Date |
---|---|
Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity Grant 8,846,639 - Swayze , et al. September 30, 2 | 2014-09-30 |
Antidotes To Antisense Compounds App 20100331392 - Monia; Brett P. ;   et al. | 2010-12-30 |
Systems and method of a gated electrospray interface with variable flow rate for high throughput mass spectrometric analysis Grant 7,095,017 - Hofstadler , et al. August 22, 2 | 2006-08-22 |
Derivatized oligonucleotides having improved uptake and other properties App 20020177150 - Manoharan, Muthiah ;   et al. | 2002-11-28 |
Antisense modulation of PI3 kinase p110 beta expression Grant 6,133,032 - Monia , et al. October 17, 2 | 2000-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.